Georgia Code
Part 1 - Schedules, Offenses, and Penalties
§ 16-13-28. Schedule Iv

(1.5) Armodafinil;
(2.05) Brexanolone;
(2.1) Bromazepam;
(2.15) Butorphanol;
(2.25) Carisoprodol;
(2.3) Cathine;
(5.1) Clobazam;
(8.1) Deschloroetizolam;
(8.5) Dexfenfluramine;
(11.05) Difenoxin;
(11.5) Eluxadoline;
(13.15) Etizolam;
(13.2) Fencamfamin;
(14.2) Fenproporex;
(14.5) Fluclotizolam;
(16.5) Lemborexant;
(19.2) Mefenorex;
(22.1) Modafinil;
(29.1) Pipradrol;
(30.05) Propoxyphene (including all salts and optical isomers);
(30.07) Pyrazolam;
(30.1) Quazepam;
(30.15) Remimazolam;
(30.17) Serdexmethylphenidate;
(30.2) Sibutramine;
(30.25) Solriamfetol, including its salts, isomers, and salts of isomers;
(30.3) SPA (-)-1-dimethylamino-1, 2-diphenylethane;
(30.5) Suvorexant;
(31.5) Tramadol [2-((dimethylamino)methyl)-1-(3-methoxy-phenyl) cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers];
History. Code 1933, § 79A-809, enacted by Ga. L. 1974, p. 221, § 1; Ga. L. 1977, p. 1287, § 1; Ga. L. 1979, p. 859, § 8; Ga. L. 1980, p. 1746, § 7; Ga. L. 1981, p. 557, § 4; Ga. L. 1982, p. 3, § 16; Ga. L. 1982, p. 2403, §§ 14, 19; Ga. L. 1984, p. 22, § 16; Ga. L. 1985, p. 1219, § 4; Ga. L. 1986, p. 10, § 16; Ga. L. 1986, p. 1555, § 4; Ga. L. 1987, p. 261, § 5; Ga. L. 1989, p. 233, § 4; Ga. L. 1990, p. 8, § 16; Ga. L. 1993, p. 590, § 2; Ga. L. 1994, p. 169, § 5; Ga. L. 1996, p. 1023, § 1; Ga. L. 1997, p. 1311, § 3; Ga. L. 1998, p. 778, § 2; Ga. L. 1999, p. 643, § 1; Ga. L. 2000, p. 1317, § 3; Ga. L. 2003, p. 349, § 4; Ga. L. 2006, p. 219, § 2/HB 1054; Ga. L. 2007, p. 47, § 16/SB 103; Ga. L. 2008, p. 169, § 5/HB 1090; Ga. L. 2009, p. 126, §§ 3, 4/HB 368; Ga. L. 2010, p. 860, § 3/SB 353; Ga. L. 2011, p. 656, § 5/SB 93; Ga. L. 2014, p. 217, § 5/HB 835; Ga. L. 2015, p. 883, § 4/HB 211; Ga. L. 2016, p. 798, § 4/HB 783; Ga. L. 2017, p. 14, § 7/HB 231; Ga. L. 2019, p. 820, § 2/HB 483; Ga. L. 2020, p. 16, § 1/HB 759; Ga. L. 2021, p. 386, § 6/HB 367; Ga. L. 2022, p. 803, § 6/HB 963.
The 2016 amendment, effective May 3, 2016, in subsection (a), deleted paragraph (a)(0.5), which read: “Alfaxalone;”, substituted “Alfaxalone” for “Alprazolam” in paragraph (a)(1), deleted paragraph (a)(2.2), which read: “Camazepam;”, substituted “Reserved” for “Clonazepam” in paragraph (a)(6), deleted paragraph (a)(7), which read: “Clorazepate;”, redesignated former paragraph (a)(7.1) as present paragraph (a)(7), deleted paragraph (a)(7.2), which read: “Cloxazolam;”, deleted paragraph (a)(7.3), which read: “Delorazepam;”, substituted “Reserved” for “Desmethyldiazepam” in paragraph (a)(8), substituted “Reserved” for “Diazepam” in paragraph (a)(10), deleted paragraph (a)(11.1), which read: “Estazolam;”, added paragraph (a)(11.5), deleted paragraph (a)(13.1), which read: “Ethyl loflazepate”, deleted paragraph (a)(14.1), which read: “Flunitrazepam;”, deleted paragraph (a)(15), which read: “Flurazepam;”, redesignated former paragraph (a)(15.3) as present paragraph (a)(15), deleted paragraph (a)(16), which read: “Halazepam;”, deleted paragraph (a)(16.1), which read: “Haloxazolam;”, redesignated former paragraph (a)(16.15) as present paragraph (a)(16), deleted paragraph (a)(16.2), which read: “Ketazolam;”, deleted paragraph (a)(16.3), which read: “Lometazepam;”, deleted paragraph (a)(16.4), which read: “Loprazolam;”, deleted paragraph (a)(17), which read: “Lorazepam;”, redesignated former paragraph (a)(17.5) as present paragraph (a)(17), deleted paragraph (a)(19.1), which read: “Medazepam;”, deleted paragraph (a)(22.1), which read: “Midazolam;”, redesignated former paragraph (a)(22.15) as present paragraph (a)(22.1), deleted paragraph (a)(22.2), which read: “Nimetazepam;”, deleted paragraph (a)(22.3), which read: “Nitrazepam;”, deleted paragraph (a)(22.4), which read: “Nordiazepam;”, substituted “Reserved” for “Oxazepam” in paragraph (a)(23), deleted paragraph (a)(23.1), which read: “Oxazolam;”, deleted paragraph (a)(27.5), which read: “Phenazepam;”, deleted paragraph (a)(30), which read: “Prazepam;”, redesignated former paragraph (a)(30.03) as present paragraph (a)(30), added paragraph (a)(30.07), substituted “Reserved” for “Temazepam” in paragraph (a)(31), deleted paragraph (a)(32), which read: “Triazolam;”, and redesignated former paragraph (a)(32.5) as present paragraph (a)(32); added subsection (b); redesignated former subsection (b) as present subsection (c), and, in subsection (c), inserted “or (b)” near the middle.
The 2017 amendment, effective April 17, 2017, added “or a thione” at the end of paragraph (b)(1).
The 2019 amendment, effective May 7, 2019, added “(including its salts, isomers, and salts of isomers)” at the end of paragraph (a)(34).
The 2020 amendment, effective June 29, 2020, added paragraph (a)(30.25).
The 2021 amendment, effective May 4, 2021, in subsection (a), added paragraphs (a)(2.05), (a)(8.1), (a)(16.5), and (a)(30.15).
The 2022 amendment, effective May 13, 2022, added paragraphs (a)(14.5) and (a)(30.17).
Code Commission notes.
Pursuant to Code Section 28-9-5, in 1998, the new paragraph added in 1998 was redesignated as paragraph (a)(30.2), and former paragraph (a)(30.2) was redesignated as paragraph (a)(30.3).
Administrative rules and regulations.
Registration requirements under the Georgia Controlled Substances Act, Official Compilation of the Rules and Regulations of the State of Georgia, Rules of Georgia State Board of Pharmacy, Chapter 480-20. Requirements of a prescription drug order, Official Compilation of the Rules and Regulations of the State of Georgia, Rules of Georgia State Board of Pharmacy, Chapter 480-22.

Structure Georgia Code